智通财经APP获悉，健倍苗苗(02161)跌超12%，截至发稿，跌12.28%，报2港元，成交额419.82万港元。
消息面上，健倍苗苗公布截至2026年3月31日止年度业绩，收益约为8.35亿港元，同比增加约6.7%；公司权益持有人应占溢利约2.01亿港元，同比增加约1.9%；每股盈利24.63港仙，末期股息每股7.35港仙。公告称，收益增长主要受品牌药及品牌中药分部的强劲表现所带动，部分与健康保健品的逊色表现所抵销。
智通财经APP获悉，健倍苗苗(02161)跌超12%，截至发稿，跌12.28%，报2港元，成交额419.82万港元。
消息面上，健倍苗苗公布截至2026年3月31日止年度业绩，收益约为8.35亿港元，同比增加约6.7%；公司权益持有人应占溢利约2.01亿港元，同比增加约1.9%；每股盈利24.63港仙，末期股息每股7.35港仙。公告称，收益增长主要受品牌药及品牌中药分部的强劲表现所带动，部分与健康保健品的逊色表现所抵销。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.